1. From the Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung and Blood Institute (NHLBI), the Cell Processing Section, Department of Transfusion Medicine, and the Clinical Center, National Institutes of Health, Bethesda, MD; and the Cancer Immunobiology Center and Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX.